Stocks · News reference
POMDOCTOR shares are trading higher after the company announced plans to terminate its ADR program and directly list its Class A ordinary shares on the Nasdaq.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Pomdoctor To Terminate Its ADR Program And List Its Class A Ordinary Shares Directly On The Nasdaq
The termination was previously approved by the board of directors of Pomdoctor on September 3, 2026 and approved by the Company's shareholders on a non-binding advisory basis at the extraordinary general meeting of
Pomdoctor In Nasdaq’s Delisting List
The company has been targeted in an aggressive two-year-old campaign to delist suspicious Chinese companies from Wall Street image credit: Bamboo Works Key Takeaways: Here today, gone tomorrow. That